Risk of Hepatocellular Carcinoma after DAA Treatment in Cirrhotic HIV\textendashHCV-coinfected Patients: Where Do We Stand? - Sorbonne Université
Journal Articles AIDS Year : 2018

Risk of Hepatocellular Carcinoma after DAA Treatment in Cirrhotic HIV\textendashHCV-coinfected Patients: Where Do We Stand?

Domains

Life Sciences [q-bio]

Gestionnaire HAL 4 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03703935

Submitted on : Friday, June 24, 2022-2:13:10 PM

Last modification on : Friday, November 8, 2024-3:21:35 AM

Consult the full text

Dates and versions

hal-03703935 , version 1 (24-06-2022)

Identifiers

Cite

Karine Lacombe. Risk of Hepatocellular Carcinoma after DAA Treatment in Cirrhotic HIV\textendashHCV-coinfected Patients: Where Do We Stand?. AIDS, 2018, 32 (11), pp.1533--1534. ⟨10.1097/QAD.0000000000001823⟩. ⟨hal-03703935⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

IPLESP SORBONNE-UNIVERSITE SU-MEDECINE
5 View
0 Download

Altmetric

Share

More